Nav: Home

Public trust in science spiked after media coverage of Zika vaccine trial

July 31, 2017

How can the public's confidence in science be strengthened?

Public trust in science has largely held steady for decades, despite short-term fluctuations. But new findings based on a survey of public attitudes toward the Zika vaccine suggest that there is a way to increase public support for science.

The study, published in the August issue of the journal Science Communication, examines what happened in August 2016 after the launch of the first human trial of a Zika vaccine. Following widespread media coverage of the trial, people paid more attention to news about the Zika virus and showed greater trust in science. The spike in public confidence in science lasted just two weeks, though the heightened attention to the Zika virus persisted for six weeks.

"For two weeks following the vaccine announcement, people were more likely to agree that science enables us to solve almost any problem," said Joseph Hilgard, a former postdoctoral fellow at the Annenberg Public Policy Center (APPC) of the University of Pennsylvania. Hilgard co-authored the study with APPC Director Kathleen Hall Jamieson.

The study is based on data from the policy center's Annenberg Science Knowledge (ASK) survey, a weekly national telephone survey of U.S. adults. The researchers analyzed 31 weeks of survey data, starting in February 2016, with a total sample of 34,266 responses. The survey respondents were asked which of these two statements comes closer to their view: "Science enables us to overcome almost any problem" or "Science creates unintended consequences and replaces older problems with new ones." (Permitted responses also included "both" and "it depends.")

In the weeks following the vaccine trial, there was "a significant, albeit short term, increase in an otherwise stable indicator of confidence in science," the researchers said.

"This finding opens the possibility that confidence in science could be bolstered in a more sustained fashion by regularized communication about advances made by science," the researchers said. "These communications may be particularly effective when they provide potential solutions to problems placed by media on the national agenda."

Hilgard and Jamieson wrote that attitudes toward science are linked with personal values and social identities, and a vaccine for the mosquito-borne Zika virus is a notably uncontroversial solution. Unlike other Zika remedies, such as aerial spraying or the release of genetically modified mosquitoes, a vaccine "does not conflict with mainstream public values or cultural norms," the study said.

There are limitations to the research, said Hilgard, an assistant professor of social psychology at Illinois State University. The ASK survey, which asked respondents for their opinions of the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), found that "opinions toward the CDC or the NIH did not warm" during this period despite the increase in media coverage of the directors of both agencies.

Nor was there a change in confidence in the federal government's ability to respond effectively to a Zika outbreak. It is possible, Hilgard said, that those survey results were affected by people's attitudes toward government rather than science.

The two-week increase in trust in science is consistent with the duration of media effects seen in political campaigns, such as messaging in ads, the study said. But unless that bolstered credibility is reinforced, it "is likely to be relatively brief even under the best of circumstances." Attempts to raise confidence, the researchers said, may "backfire if the public feels that a problem or its solution is overstated for the personal benefit of scientists, politicians, or the media, although further empirical research is needed."

Despite the overall stability of trust in science, public confidence has dipped when government officials offered assurances that proved to be false. For instance, the mishandling of "mad cow disease" in Britain during the 1990s led to a loss of trust in government institutions, the study notes. Similarly, in the United States in 2014, attitudes toward the CDC took a short-term plunge after officials inaccurately claimed that U.S. hospitals were prepared to deal with the Ebola virus.
-end-
The study "Does a Scientific Breakthrough Increase Confidence in Science? News of a Zika Vaccine and Trust in Science" is in the August 2017 issue of Science Communication: Linking Theory and Practice.

The Annenberg Public Policy Center was established in 1994 to educate the public and policy makers about the media's role in advancing public understanding of political, health, and science issues at the local, state and federal levels.

Annenberg Public Policy Center of the University of Pennsylvania

Related Vaccine Articles:

Development of a novel vaccine for Zika
Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100 percent protection in mice.
Could there be a 'social vaccine' for malaria?
Malaria is a global killer and a world health concern.
'Dose sparing' flu vaccine could boost productivity and vaccine availability
The currently licensed seasonal trivalent influenza vaccines contain 15 micrograms of viral hemagglutinin protein per strain for adults, and up to 60 micrograms for elderly individuals; however, due to recent shortages, reducing these doses would be highly desirable.
Antibodies triggered by avian influenza virus vaccine illuminate a new path toward a universal flu vaccine
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide.
Particulate vaccine delivery systems may help
Most traditional vaccines have safety and efficacy issues, whereas particulate vaccine delivery systems -- which utilize nano- or micro-particulate carriers to protect and deliver antigens--are efficient, stable, include molecules to bolster immune responses, and minimize adverse reactions due to the use of biocompatible biomaterials.
More Vaccine News and Vaccine Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...